Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $4.6 million.

  • Iradimed's Other Operating Expenses rose 2200.71% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year increase of 2013.98%. This contributed to the annual value of -$3871.0 for FY2024, which is 6896.5% up from last year.
  • Iradimed's Other Operating Expenses amounted to $4.6 million in Q3 2025, which was up 2200.71% from $4.0 million recorded in Q2 2025.
  • Iradimed's Other Operating Expenses' 5-year high stood at $4.6 million during Q3 2025, with a 5-year trough of $793716.0 in Q1 2023.
  • Its 5-year average for Other Operating Expenses is $3.2 million, with a median of $3.1 million in 2021.
  • Per our database at Business Quant, Iradimed's Other Operating Expenses crashed by 7414.23% in 2023 and then soared by 38218.32% in 2024.
  • Quarter analysis of 5 years shows Iradimed's Other Operating Expenses stood at $3.1 million in 2021, then grew by 17.43% to $3.7 million in 2022, then decreased by 9.16% to $3.3 million in 2023, then skyrocketed by 35.69% to $4.5 million in 2024, then rose by 2.5% to $4.6 million in 2025.
  • Its Other Operating Expenses was $4.6 million in Q3 2025, compared to $4.0 million in Q2 2025 and $4.2 million in Q1 2025.